Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variants

MLA

Kai Lin, et al. “Inhibitors of Hepatitis C Virus NS3·4A Protease. Part 3: P2 Proline Variants.” Bioorganic & Medicinal Chemistry Letters, vol. 14, Apr. 2004, pp. 1939–42. EBSCOhost, https://doi.org/10.1016/j.bmcl.2004.01.078.

APA

Kai Lin, Joseph L. Kim, Yu-Ping Luong, Janos Pitlik, Wayne C. Schairer, Chao Lin, Roger D. Tung, Robert B. Perni, John A. Thomson, John Maxwell, Luc J. Farmer, Kevin M. Cottrell, Murcko Mark A, Lawrence F. Courtney, Cynthia A. Gates, John J. Court, John H. Van Drie, David D. Deininger, Wilson Keith P, … Scott L. Harbeson. (2004). Inhibitors of hepatitis C virus NS3·4A protease. Part 3: P2 proline variants. Bioorganic & Medicinal Chemistry Letters, 14, 1939–1942. https://doi.org/10.1016/j.bmcl.2004.01.078

Chicago

Kai Lin, Joseph L. Kim, Yu-Ping Luong, Janos Pitlik, Wayne C. Schairer, Chao Lin, Roger D. Tung, et al. 2004. “Inhibitors of Hepatitis C Virus NS3·4A Protease. Part 3: P2 Proline Variants.” Bioorganic & Medicinal Chemistry Letters 14 (April): 1939–42. doi:10.1016/j.bmcl.2004.01.078.